
<!DOCTYPE html>
<html>
<meta charset="UTF-8">
<head>
  <title>Topic 07 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 75 - 15 Topics</title>

<style>
table {
  font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
  border-collapse: collapse;
  width: 100%;
}

td, th {
  border: 1px solid #ddd;
  padding: 8px;
}

tr:nth-child(even){background-color: #f2f2f2;}

tr:hover {background-color: #ddd;}

th {
  padding-top: 12px;
  padding-bottom: 12px;
  text-align: left;
  background-color: #0099FF;
  color: white;
}
</style>

</head>
<body>
<h2>Topic 07 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 75 - 15 Topics</h2>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>cite ad</th>
      <th>title</th>
      <th>authors</th>
      <th>publish year</th>
      <th>publish time</th>
      <th>dataset</th>
      <th>abstract mentions covid</th>
      <th>pmcid</th>
      <th>pubmed id</th>
      <th>doi</th>
      <th>cord uid</th>
      <th>topic weight</th>
      <th>Similarity scispacy</th>
      <th>Similarity specter</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th id="fmtfzlb1";>1</th>
      <td>Zhu_X_2016</td>
      <td>TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAKâ€“STAT signaling pathway</td>
      <td>Zhu, X; Xie, C; Li, Y-m; Huang, Z-l; Zhao, Q-y; Hu, Z-x; Wang, P-p; Gu, Y-r; Gao, Z-l; Peng, L</td>
      <td>2016</td>
      <td>2016-06-02</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143376" target="_blank">PMC5143376</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/27253403.0" target="_blank">27253403.0</a></td>
      <td><a href="https://doi.org/10.1038/cddis.2016.146" target="_blank">10.1038/cddis.2016.146</a></td>
      <td>fmtfzlb1</td>
      <td>0.998357</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="ql6zo8ka";>2</th>
      <td>Li_D_2017</td>
      <td>A potent human neutralizing antibody Fc-dependently reduces established HBV infections</td>
      <td>Li, Dan; He, Wenhui; Liu, Ximing; Zheng, Sanduo; Qi, Yonghe; Li, Huiyu; Mao, Fengfeng; Liu, Juan; Sun, Yinyan; Pan, Lijing; Du, Kaixin; Ye, Keqiong; Li, Wenhui; Sui, Jianhua</td>
      <td>2017</td>
      <td>2017-09-26</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614562" target="_blank">PMC5614562</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/28949917.0" target="_blank">28949917.0</a></td>
      <td><a href="https://doi.org/10.7554/elife.26738" target="_blank">10.7554/elife.26738</a></td>
      <td>ql6zo8ka</td>
      <td>0.811136</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="0808xjeq";>3</th>
      <td>Fukuhara_2011</td>
      <td>Intracellular delivery of serum-derived hepatitis C virus</td>
      <td>Fukuhara, Takasuke; Tani, Hideki; Shiokawa, Mai; Goto, Yukinori; Abe, Takayuki; Taketomi, Akinobu; Shirabe, Ken; Maehara, Yoshihiko; Matsuura, Yoshiharu</td>
      <td>2011</td>
      <td>2011-04-30</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129305" target="_blank">PMC7129305</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/21262370.0" target="_blank">21262370.0</a></td>
      <td><a href="https://doi.org/10.1016/j.micinf.2011.01.005" target="_blank">10.1016/j.micinf.2011.01.005</a></td>
      <td>0808xjeq</td>
      <td>0.607328</td>
      <td></td>
      <td></td>
    </tr>
  </tbody>
</table>
</body>
</html>
